SCHEMBL2705970

SCHEMBL2705970

CC(=O)Oc1ccc(Sc2ccc(C(=O)Cl)cc2)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 3/20 0.43
RAB9A P51151 3/20 0.43
TSHR P16473 2/20 0.43
GAA P10253 2/20 0.43
LMNA P02545 4/20 0.42
HPGD P15428 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
TOP1 P11387 2/20 0.37
CYP3A4 P08684 1/20 0.36
ALOX12 P18054 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CFD P00746 2/20 0.36
GLA P06280 1/20 0.35
GFER P55789 1/20 0.35
MAPT P10636 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PPARD Q03181 1/20 0.34
PKM P14618 3/20 0.33
NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705266 0.89 TSHR (0.54) KDM4EALDH1A1RAB9ATSHRGAA
SCHEMBL13049324 0.85 LMNA (0.43) KDM4EALDH1A1RAB9ATSHRGAA
SCHEMBL9735399 0.83 TSHR (0.51) KDM4EALDH1A1RAB9ATSHRGAA
SCHEMBL3759591 0.82 TTR (0.39) KDM4EALDH1A1RAB9ATSHRGAA
SCHEMBL2706325 0.77 TSHR (0.50) KDM4EALDH1A1RAB9ATSHRGAA
SCHEMBL11149185 0.76 ELANE (0.36) TSHRLMNAHPGDL3MBTL1TDP1
SCHEMBL7138086 0.74 HPGD (0.58) KDM4EALDH1A1RAB9ATSHRLMNA
SCHEMBL6047542 0.73 TSHR (0.71) KDM4EALDH1A1RAB9ATSHRGAA
SCHEMBL5322367 0.73 HPGD (0.68) ALDH1A1TSHRLMNAHPGDL3MBTL1
SCHEMBL8830836 0.73 TSHR (0.70) KDM4EALDH1A1RAB9ATSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2435462-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS Pfizer Limited (GB) 2012-04-04 EP disclosed
WO-2010136940-A1 NOVEL GLUCOCORTICOID RECEPTOR AGONISTS PFIZER LIMITED (GB) 2010-12-02 WO disclosed
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists GLOSSOP PAUL ALAN 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100303758-A1 Novel Glucocorticoid Receptor Agonists NR3C1, NR3C2, MC2R KDM4E 3887/4885ALDH1A1 2013/4885RAB9A 2234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.